We pursue selected, shared risk /reward partnerships to develop internal IP programmes that address major unmet medical needs.

We combine our internal expertise in venom biology and drug discovery with that of partners who have developed unique phenotypic assays or other biologic tools for identifying drug leads in our venoms' components.


We expect that some of these programmes will generate IP-protected molecules that increase the value of the company. Please contact us to discuss a partnership with Venomtech.